Effects of the Lung Carcinogen Silica on Cyclooxygenase-2 and Prostaglandin E2 Expression in RAW 264.7 Cells
Public Domain
-
2002/04/06
Details
-
Personal Author:
-
Description:Silica is a mineral which is associated with a number of lung diseases, including lung cancer, mesothelioma and silicosis. Elevated levels of the proteins Cyclooxygenase-2 (Cox-2) and Prostaglandin E2 (PGE2) synthase have been observed in lung cancer in a number of in vitro and in vivo studies. Few studies have examined the link between silica exposure and the expression of Cox-2 and PGE2 synthase, however. The purpose of this study was to investigate the effects of silica on Cox-2 and PGE2 synthase expression in RAW 264.7 mouse macrophage cells. RAW cells were incubated with silica at 0, 10, 50, 100 or 1,000 microg/ml for 12 hours. As a positive control for Cox-2 expression, lipopolysaccharide (LPS) was administered for 12 hours to a 6th treatment group at 10 microg/ml. Silica treatment induced Cox-2 and PGE2 protein expression in a dose-dependent manner. The highest dose silica-treated group induced Cox-2 to a greater degree, than did the LPS positive control. Based on previous studies in our laboratory which indicated that silica affects signal transduction pathways upstream of Cox-2, particularly those associated with MAP Kinase pathways, further studies were conducted using specific inhibitors. Using the highest (1,000 microg/ml silica dose, the inhibitors SB 203580 (a p38 MAP Kinase Inhibitor), PD 98059 (a MEK1 Inhibitor for ERK), UO126 (an ERK inhibitor), Calpain Inhibitor I (an NFkB Inhibitor), and Cannabinol (a CREB/ATF:1 Inhibitor) were tested for their effects on Cox-2 expression. Only SB 203580 attenuated Cox-2 protein expression. The results of this study indicate that silica exposure induces both Cox-2 and PGE2 expression and that silica-induced Cox-2 expression is partially dependent on p38 MAP Kinase. [Description provided by NIOSH]
-
Subjects:
-
Keywords:
-
ISSN:0197-016X
-
Publisher:
-
Document Type:
-
Genre:
-
Place as Subject:
-
CIO:
-
Division:
-
Topic:
-
Location:
-
Volume:43
-
NIOSHTIC Number:nn:20033745
-
Citation:Proceedings of the 93rd American Association for Cancer Research Annual Meeting, April 6-10, 2002, San Francisco, California. Philadelphia, PA: American Association for Cancer Research, 2002 Apr; 43:470
-
CAS Registry Number:
-
Federal Fiscal Year:2002
-
NORA Priority Area:
-
Peer Reviewed:False
-
Source Full Name:Proceedings of the 93rd American Association for Cancer Research Annual Meeting, April 6-10, 2002, San Francisco, California
-
Collection(s):
-
Main Document Checksum:urn:sha-512:6596c3cd58c514d87b748aa3f79e5762167af71d0a697b2ea08608efaf4e3971c1b886e236e52909969c531b34c00d4502effc15830023825ebbb9139482cbcc
-
Download URL:
-
File Type:
ON THIS PAGE
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings,
journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like